A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma
Condition(s):AsthmaLast Updated:December 28, 2012Completed
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:December 28, 2012Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:August 11, 2016Unknown status
Condition(s):Focal Segmental GlomerulosclerosisLast Updated:August 11, 2009Unknown status
Condition(s):Idiopathic Membranous NephropathyLast Updated:February 17, 2022Terminated
Condition(s):Immune Thrombocytopenia; Glucocorticoids; Child, OnlyLast Updated:March 1, 2023Recruiting
Condition(s):Prostate Cancer Metastatic; Prostate CancerLast Updated:October 12, 2023Recruiting
Condition(s):Heart FailureLast Updated:August 28, 2013Completed
Condition(s):Prostate Neoplasms; Prostate CancerLast Updated:July 25, 2014Completed
Condition(s):Inflammatory Bowel Disease 11Last Updated:November 2, 2016Completed
Condition(s):Tinnitus, Subjective; Hidden Hearing LossLast Updated:March 7, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.